biuro@scopefluidics.com +48 22 376 21 14

About
Team
Our offer
Knowledge base
News
Investor relations
Career
Contact

biuro@scopefluidics.com +48 22 376 21 14

About
Team
Our offer
Knowledge base
News
Investor relations
Career
Contact

biuro@scopefluidics.com +48 22 376 21 14

RAPORT ESPI 6/2025 | 03-04-2025 | Decyzja Zarządu dotycząca procesu certyfikacji FDA dla systemu BACTEROMIC

Previous PostRAPORT ESPI 5/2025 | 28-02-2025 | Rozszerzenie współpracy z BIT w ramach projektu BACTEROMICNext PostRAPORT ESPI 7/2025 | 23-04-2025| Decyzja Zarządu dotycząca wniosku do ZWZ dotyczącego podziału zysku za 2024 rok

0Shares

Related Posts

Our Scope Fluidics Fellowship program has officially launched

Scope Fluidics after Q1 2025: Focus on Project Development

Scope Fluidics Launches Fellowship Program for Young Scientists with Project Budgets of up to PLN 1 Million

CONTACT US

Tel. +48 22 376 21 14
Email: biuro@scopefluidics.com

Address

Ogrodowa 58
9th floor
00-876 Warsaw

KRS: 0000668408

NIP: 527-264-59-89

REGON: 142-754-170

LEI: 259400EUNFX4E2BEHU15

Company registered in the District Court for the Capital City of Warsaw in Warsaw, XII Commercial Division of the National Court Register.

Share capital: PLN 272 593,00 fully paid up

Bank Account Number: 03 2490 0005 0000 4520 3046 2136

Terms of use

Cookies Policy

Information clause

Whistleblower Protection

Scope Fluidics 2021 ® All rights reserved